SCHEMBL13539596

SCHEMBL13539596

CCOC(=N)Cc1ccsc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
LMNA P02545 3/20 0.44
TSHR P16473 1/20 0.44
SIRT5 Q9NXA8 1/20 0.42
HTT P42858 1/20 0.42
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39
DRD2 P14416 1/20 0.39
DRD3 P35462 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3483778 0.98 CYP1A2 (0.51) CYP1A2CYP2C9CYP2C19LMNATSHR
SCHEMBL359468 0.79 CYP1A2 (0.60) CYP1A2CYP2C9CYP2C19LMNATSHR
Hydrochloric Acid SCHEMBL8805954 0.76 ALDH1A1 (0.40) CYP1A2CYP2C9CYP2C19TSHRSIRT5
SCHEMBL31115245 0.73 CYP1A2 (0.55) CYP1A2CYP2C9CYP2C19LMNATSHR
SCHEMBL5644713 0.73 CYP1A2 (0.55) CYP1A2CYP2C9CYP2C19LMNATSHR
SCHEMBL506200 0.73 KMT2A (0.43) LMNATSHRTP53POLBKMT2A
Bromide SCHEMBL9729336 0.72 KMT2A (0.42) LMNATSHRTP53POLBKMT2A
SCHEMBL12390375 0.72 ESR1 (0.46) LMNATP53KMT2AALDH1A1
Hydrochloric Acid SCHEMBL13836304 0.72 MEN1 (0.46) LMNAPOLBKMT2AMEN1ALDH1A1
Hydrochloric Acid SCHEMBL506846 0.72 KMT2A (0.42) LMNATSHRTP53POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
WO-2008012470-A2 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATION AND USES GENFIT (FR) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES IPO5, PPIP5K2, IPO4 CYP1A2 45/4885CYP2C9 62/4885CYP2C19 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.